📉 What Happened Today
Indian equity markets opened the week in the red on Monday, April 6, as the ghost of geopolitical uncertainty continued to haunt Dalal Street. The BSE Sensex slipped 241 points to trade near 73,079, while the NIFTY 50 shed 85 points to hover around 22,628 — marking the sixth consecutive week of decline for benchmark indices.
This was the first trading session after the Good Friday holiday, and the mood was far from festive. Broad-based selling was visible across sectors, with Pharma, Oil & Gas, Healthcare, Media, Realty, Defence, Private Banks, and Infrastructure all trading in the red. The Nifty Pharma index was the hardest hit, declining nearly 1%.
On the brighter side, select stocks like Wipro, Hindalco Industries, Titan Company, and Trent managed to swim against the tide, ending among the top gainers. Meanwhile, Kotak Mahindra Bank, InterGlobe Aviation (IndiGo), Tata Steel, and Bajaj Finance led the losers’ pack.
🌍 Why It Happened — The Three Forces at Play
1. The Iran-US Conflict — Oil’s Reign of Terror: The US-Iran conflict, now entering its sixth week since strikes began on February 28, continues to dominate global risk sentiment. Crude oil prices have surged to $111.81 per barrel (WTI) — up over 50% since the beginning of the year. Brent crude is trading at $115. Disruptions in Strait of Hormuz shipping and Middle East production shutdowns are keeping energy prices elevated. For an import-dependent economy like India, this is a direct threat to corporate margins, inflation, and the current account deficit.
2. Relentless FII Selling: Foreign Institutional Investors (FIIs) continued their selling spree, offloading a massive ₹9,931 crore on April 2 alone. This persistent outflow has been one of the biggest headwinds for Indian markets. The silver lining? Domestic Institutional Investors (DIIs) stepped in as net buyers to the tune of ₹7,208 crore — a reminder that Indian institutional money still believes in the India growth story.
3. Rupee Under Pressure: The Indian Rupee traded weak near 92.86 against the US Dollar, weighed down by surging crude prices and FII outflows. A weaker rupee makes imports costlier and adds to inflationary pressures — but it also makes Indian IT exports more competitive, which partly explains why Wipro outperformed today.
💡 What It Means for Investors
Let’s be absolutely clear: this is not the time to panic. A 0.3-0.4% decline in a single session, while unsettling against the backdrop of a six-week slide, is not a crash. It’s a market doing what markets do — repricing risk in the face of genuine uncertainty.
Here’s what experienced investors understand that the crowd doesn’t: geopolitical shocks are historically temporary. According to Deutsche Bank’s analysis of past conflicts, stocks typically fall about 6% in the first three weeks of a geopolitical shock before recovering completely in the following three weeks. Morgan Stanley’s research echoes the same — once the trajectory of a conflict becomes clearer, markets stabilize and often rebound sharply.
The real risk isn’t the war itself — it’s what you do in response to it. Investors who sold in panic during the 2020 COVID crash, the 2022 Russia-Ukraine conflict, or the 2008 financial crisis locked in permanent losses. Those who held quality — or better yet, bought quality at discounted prices — went on to make extraordinary returns.
📚 The Value Investor’s Perspective
What would Warren Buffett say about today’s market? We don’t need to guess — he’s told us many times:
“Be fearful when others are greedy, and greedy when others are fearful.”
Right now, fear is running high. FIIs are dumping stocks. Headlines scream about war. Oil prices are surging. The crowd is terrified. And yet — India’s GDP is still growing, corporate earnings season is around the corner, and quality businesses continue to execute their strategies regardless of what happens in the Strait of Hormuz.
Benjamin Graham reminded us that “the stock market is a voting machine in the short run, but a weighing machine in the long run.” Today, the market is voting on fear. But over the next 3-5 years, it will weigh the actual earnings, cash flows, and competitive advantages of the businesses you own.
And here’s something the so-called “experts” won’t tell you: wide diversification is only required when investors do not understand what they are doing — that’s Buffett’s own words. The greatest investors in history — Buffett, Charlie Munger, Mohnish Pabrai, Rakesh Jhunjhunwala — they didn’t make their fortunes by spreading money across 50 mediocre stocks. They made concentrated bets on deeply researched, high-conviction ideas. If you truly understand a business using deep fundamental analysis, you should concentrate your capital in your best 5-10 ideas, not dilute returns chasing false safety through diversification.
💎 Titan Biotech — Quality Compounding Through the Chaos
While the market panics about geopolitics and FII selling, quality compounders continue doing what they do best — growing their business. Titan Biotech delivered a staggering 94% profit growth last quarter while the rest of the market was busy watching news headlines and pressing the sell button.
This is the fundamental difference between price and value. The stock price may fluctuate with market sentiment, but the business underneath keeps compounding. When you own a company growing profits at 94% year-over-year, short-term market noise is just that — noise. This is exactly the kind of business that creates multibagger wealth for patient, conviction-driven investors.
✅ Your Action Plan for This Week
1. Don’t sell quality in panic. If you own fundamentally strong businesses with growing earnings, healthy balance sheets, and competitive moats — hold them. Better yet, if you have cash on the sidelines, consider this a potential opportunity to add at lower prices.
2. Focus on business fundamentals, not headlines. Turn off the news ticker. Open the annual reports. Study the quarterly results. The companies that survive and thrive through geopolitical turmoil are the ones you want to own for the next decade.
3. Use our 95-factor framework. At , we’ve built a comprehensive framework to evaluate businesses deeply. This is how you build conviction — not through tips, not through CNBC, but through rigorous fundamental analysis.
⚠️ STAY AWAY FROM F&O — This Is Not Investing
In volatile markets like today, the temptation to “trade the swings” through Futures & Options is dangerously high. Let me be blunt: F&O is not investing — it’s gambling with leverage. SEBI’s own data shows that over 90% of individual F&O traders lose money. In a market driven by geopolitical surprises that no one can predict, leveraged positions can wipe out your capital overnight.
Real wealth is built through patient, long-term investing in quality businesses — not through speculative bets on short-term price movements.
🎓 Learn Value Investing the Right Way
Watch our complete value investing course playlist — free on YouTube.
Stay calm. Stay invested in quality. Think long-term.
— Manish Goel, Founder,
Disclaimer: This article is for educational and informational purposes only. It is not investment advice, and not a buy, sell, or hold recommendation on any stock mentioned, including Titan Biotech Limited. Equity markets carry risk; please do your own research or consult a qualified professional before making investment decisions.
